Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 24 device-driven procedures, CMS 2024
Not enough data yet.
Not enough data yet.
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Decompression & minimally invasive spine | 7 | 234−1.1%/yr | −1.1%/yr | 1.80.5× | 12% | 140 in 2030−8.4%/yr |
| Lumbar fusion |
How the numbers are made · Every state · Compare two markets
Share of the named cases done by the 10 busiest surgeons.
| 4 |
| 124−3.3%/yr |
| −3.3%/yr |
| 0.90.3× |
| 36% |
| 150 in 2030+3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Debridement & negative-pressure wound therapy | 32 | 8,764−0.8%/yr | −0.8%/yr | 64.90.7× | 38% | 9,750 in 2030+1.8%/yr |
| Skin substitutes & wound grafts | 3 | 546+7.6%/yr | +7.6%/yr | 2.40.2× | 74% | 1,080 in 2030+12%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Radiofrequency ablation (facet, genicular, basivertebral) | 2 | 164−13%/yr | −13%/yr | 1.20.1× | 95% | 250 in 2030+7.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Dialysis access | 8 | 567−14%/yr | −14%/yr | 4.60.9× | 62% | 560 in 2030−0.1%/yr |
| Superficial venous ablation | 4 | 442+29%/yr | +29%/yr | 3.30.6× | 100% | 390 in 2030−2.2%/yr |
| Peripheral arterial intervention | 2 | 363+2.9%/yr | +2.9%/yr | 2.70.5× | 91% | 690 in 2030+11%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Hernia repair | 2 | 372−1.1%/yr | −1.1%/yr | 3.10.5× | 4% | 390 in 2030+1%/yr |
| Cholecystectomy & appendectomy | 2 | 277−3.2%/yr | −3.2%/yr | 2.20.6× | 0% | 360 in 2030+4.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Kidney stone management | 7 | 297−1.8%/yr | −1.8%/yr | 2.30.6× | 0% | 290 in 2030−0.2%/yr |
| BPH procedures | 5 | 293−11%/yr | −11%/yr | 2.30.5× | 43% | 390 in 2030+5%/yr |
| Hysterectomy, hysteroscopy & ablation | 2 | 214+5.1%/yr | +5.1%/yr | 1.90.8× | 14% | 220 in 2030+0.1%/yr |
| Incontinence, prolapse & sacral neuromodulation | 4 | 114−4.8%/yr | −4.8%/yr | 0.90.5× | 0% | 260 in 2030+15%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 4 | 276−3.9%/yr | −3.9%/yr | 2.20.5× | 78% | 340 in 2030+3.4%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 10 | 618−1.8%/yr | −1.8%/yr | 5.20.8× | 25% | 620 in 2030−0.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| CGM & insulin pump management | 13 | 1,091+42%/yr | +42%/yr | 8.40.4× | 81% | 2,360 in 2030+14%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Pacemaker, ICD & CRT implantation | 3 | 114−16%/yr | −16%/yr | 0.90.2× | 0% | 130 in 2030+2.8%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Coronary intervention (PCI) | 9 | 344−2.3%/yr | −2.3%/yr | 2.10.5× | 0% | 570 in 2030+8.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Cataract & MIGS | 42 | 5,492−2.8%/yr | −2.8%/yr | 42.10.9× | 94% | 5,990 in 2030+1.4%/yr |
| Vitreoretinal surgery | 5 | 294−3.5%/yr | −3.5%/yr | 2.30.9× | 95% | 300 in 2030+0.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Colonoscopy & upper endoscopy | 53 | 9,802−0.3%/yr | −0.3%/yr | 80.00.8× | 46% | 11,300 in 2030+2.4%/yr |
| Bronchoscopy & lung nodule | 6 | 241+24%/yr | +24%/yr | 1.90.8× | 0% | 590 in 2030+16%/yr |
| ERCP & endoscopic ultrasound | 5 | 193−5.6%/yr | −5.6%/yr | 1.50.4× | 1% | 340 in 2030+10%/yr |
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.